The LEAP-001 study evaluated the combination of Keytruda plus Lenvima for the first-line treatment of patients with advanced or recurrent endometrial carcinoma whose disease is mismatch repair ...

The International Federation of Gynecology and Obstetrics (FIGO) staging systems for vulva, cervix, endometrium, and sarcomas have been revised for the first time in over a decade. The purpose of ...

There are two major types of uterine cancer: Adenocarcinoma of the endometrium: Cancer that develops in the glands lining the uterus, known as the endometrium; more than 95 percent of uterine cancers ...

Adenomyosis is a chronic condition in which the endometrial tissue that lines the uterus grows into the muscular wall of the uterus. Symptoms include heavy menstrual bleeding, pelvic pain ...

“If you have a womb and you’re taking HRT, you’ve got to take progesterone to reduce the risk of endometrial carcinoma,” says ...

Endometrial cancer, the most prevalent gynecologic cancer in the United States, poses a significant health risk, particularly for Black women. Recent research published in JAMA Oncology has raised ...

Estradiol 0.025mg/day, 0.0375mg/day, 0.05mg/day, 0.075mg/day, 0.1mg/day; transdermal system. Increased risk of endometrial carcinoma or hyperplasia in women with intact uterus (adding progestin is ...

The FDA has granted VLS-1488 fast track designation in patients with platinum-resistant high-grade serous ovarian cancer.

The first opinion recommends the approval of Keytruda in combination with carboplatin and paclitaxel, followed by Keytruda as a single agent, for the first-line treatment of adult patients with ...

Recent research has revealed unexpected health benefits linked to coffee, despite earlier recommendations to limit intake due ...

Repare stock gains 8% as the company initiates dosing patients in its phase I study of the RP-3467 combo regimen for advanced solid tumor indications.